Benzinga Rankings give you vital metrics on any stock – anytime.
Explore BioXcel Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BTAI.
You can purchase shares of BioXcel Therapeutics (NASDAQ:BTAI) through any online brokerage.
Other companies in BioXcel Therapeutics’s space includes: Ernexa Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), HOOKIPA Pharma (NASDAQ:HOOK), CARISMA Therapeutics (NASDAQ:CARM) and Evaxion Biotech (NASDAQ:EVAX).
BioXcel Therapeutics has a consensus price target of $13.03.
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $1.75 last updated April 11, 2025 at 1:27 AM EDT.
There are no upcoming dividends for BioXcel Therapeutics.
BioXcel Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for BioXcel Therapeutics.
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.